Pfizer's Dividend Dream: Wait for Growth episode artwork

EPISODE · May 3, 2026 · 1 MIN

Pfizer's Dividend Dream: Wait for Growth

from The Daily News Now! Business

Pfizers stock, currently undervalued due to falling COVID vaccine sales and patent cliffs, presents a lucrative opportunity for dividend-focused investors. Despite challenges, Pfizer is actively expanding its portfolio with promising drugs and strategic partnerships. Offering a high dividend yield, its a solid income play with potential for significant growth if their innovations succeed. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/b69a21e75f2b2364

NOW PLAYING

Pfizer's Dividend Dream: Wait for Growth

0:00 1:21

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 1 minute long.

When was this The Daily News Now! Business episode published?

This episode was published on May 3, 2026.

What is this episode about?

Pfizers stock, currently undervalued due to falling COVID vaccine sales and patent cliffs, presents a lucrative opportunity for dividend-focused investors. Despite challenges, Pfizer is actively expanding its portfolio with promising drugs and...

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!